Stay updated on Canagliflozin Impact on Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.

Latest updates to the Canagliflozin Impact on Heart Failure Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry v3.6.3 appears in the record history, replacing the previous v3.6.2, indicating a site update to the page rendering/metadata.SummaryDifference0.1%

- Check19 days agoChange DetectedThe study record history now shows the revision as v3.6.2, replacing v3.6.0. This is a small metadata update to the page’s version tag rather than a content change.SummaryDifference0.1%

- Check33 days agoChange DetectedThe record history now includes a recruitment status note that recruitment is closed and a new revision tag (v3.6.0); the previous revision (v3.5.5) is removed.SummaryDifference0.3%

- Check40 days agoChange DetectedA new revision label v3.5.5 is added to the history and the previous label v3.5.4 is removed, updating the documented version history.SummaryDifference0.1%

- Check61 days agoChange DetectedVersion history shows the record revised from v3.5.3 to v3.5.4. This indicates a minor update to the page's revision metadata on ClinicalTrials.gov, not affecting the displayed content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page’s displayed revision number was updated from v3.5.2 to v3.5.3, indicating a minor update to the site/app version shown in the footer. No changes to the trial record history entries themselves are indicated by this revision label update.SummaryDifference0.1%

Stay in the know with updates to Canagliflozin Impact on Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.